Stephanie Dellicour is a pharmacoepidemiologist. She obtained an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine and her PhD in Epidemiology from the University of Amsterdam. Stephanie conducted her dissertation research on the development of pharmacovigilance surveillance systems for antimalarial drugs used in pregnancy. She was based in western Kenya for four years as a visiting scientist with the KEMRI/CDC research station, where she implemented and oversaw a range of studies for the Malaria in Pregnancy Consortium.

She is currently seconded by the Medicines and Healthcare products Regulatory Agency (MHRA) to lead the MiMBa Pregnancy Registry. This is a collaboration between the Medicines for Malaria Venture, the Liverpool School of Tropical Medicines and WWARN, which aims to generate robust data on the safety of a range of antimalarials, particularly in the 1st trimester, to inform regulators and policymakers.

Her main research interests include pharmacoepidemiology, pharmacovigilance, with a focus on pregnant women.